Incident cardiovascular events and early mortality in patients with revascularized critical limb ischemia
1Vascular medicine department, Groupe Hospitalier Paris Saint-Joseph, Clinical Investigation Center, Hôpital Européen George-Pompidou, AP-HP, Paris, France.
Insights
Major adverse cardiovascular events (MACE) are common after critical limb ischemia (CLI) revascularization, increasing mortality risk. Coronary heart disease and heart failure significantly contribute to MACE in these patients.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Interventional Cardiology
Background:
- Critical limb ischemia (CLI) patients face high risks of cardiovascular events and mortality.
- Percutaneous revascularization is a common treatment for CLI, but outcomes require further investigation.
Purpose of the Study:
- To determine the incidence of major adverse cardiovascular events (MACE) and one-year mortality in CLI patients post-revascularization.
- To identify risk factors associated with MACE and mortality after endovascular procedures for CLI.
Main Methods:
- Retrospective analysis of an ongoing cohort study (November 2013 - December 2018).
- Inclusion of 285 CLI patients undergoing endovascular revascularization.
- One-year follow-up for MACE (heart failure, ACS, stroke, sudden death), mortality, and major amputations; multivariate logistic regression used for analysis.
Main Results:
- 75 (26.3%) patients experienced MACE within one year; 76 (26.7%) died, primarily from cardiovascular causes.
- MACE occurrence was significantly associated with increased mortality risk (HR 6.96).
- Coronary heart disease and decompensated heart failure were independently associated with incident MACE.
Conclusions:
- MACE are prevalent post-endovascular revascularization for CLI and are linked to higher mortality.
- Coronary heart disease and heart failure are key drivers of MACE in this population.
- Findings emphasize the need for multidisciplinary assessment before revascularization in elderly CLI patients.
Objectives:
Patients with critical limb ischemia (CLI) present a high risk of cardiovascular events and death. This study aimed to investigate the incidence of major adverse cardiovascular events (MACE) and one-year mortality in patients undergoing percutaneous revascularization procedure for CLI.
Methods:
This investigation is a retrospective analysis of an ongoing cohort study in patients with CLI undergoing endovascular revascularization, hospitalized in the vascular medicine department from November 2013 to December 2018. Major cardiovascular events were collected during the first year after revascularization procedure and were defined as heart failure, acute coronary syndrome, ischemic stroke and sudden death. Mortality and major limb amputations, defined as above-the-ankle amputation, were determined during the one-year follow-up period. Multivariate logistic regression analyses were performed to identify factors independently associated with the occurrence of MACE and one-year mortality after revascularization procedure. A P≤0.05 was considered as statistically significant.
Results:
The study included 285 consecutive patients, 157 men (55%) and 128 women (45%), with a mean age of 77.8±12 years. Treated hypertension was present in 222 (78%) patients; diabetes was present in 137 (48%) patients; 112 (39%) patients had known coronary heart disease and 20 (7%) patients were dialysis dependent. During the one-year follow-up after revascularization procedure, 75 (26.3%) patients presented an incident cardiovascular event, of whom 19 (6.7%) patients in the perioperative period. Cumulative mortality rate was 26.7% (76 patients) mostly from cardiovascular causes. Twenty-five patients (8.8%) experienced major amputation. In multivariate analysis, the occurrence of MACE was associated with an increased mortality risk (HR 6.96 (2.99-16.94), P<0.001). Other variables associated with an increased mortality were living in a nursing home and malnutrition. Decompensated heart failure and coronary heart disease were both associated with incident MACE in multivariate analysis, independently of confounders.
Conclusion:
In the present study population, incident MACE were prevalent in the year following endovascular revascularization procedure in patients with CLI and were associated with an increased risk of mortality. Coronary heart disease and decompensated heart failure are important contributors for the occurrence of MACE. In this elderly patient population with CLI, these results should be taken into account during the multidisciplinary team meeting before consideration of revascularization procedure.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
